Agilent Technologies Inc.
Agilent Technologies Reports Q1 2025 Financial Results and Outlook
Summary
Agilent Technologies, Inc. reported solid financial results for the first quarter of fiscal year 2025, with total revenue of $1.68 billion, showing a 1.4% reported growth and 1.2% core growth compared to Q1 2024. GAAP net income was $318 million, or $1.11 per share, while non-GAAP net income was $377 million, or $1.31 per share. The company confirmed its full-year revenue outlook to be between $6.68 billion and $6.76 billion, with non-GAAP EPS expected between $5.54 and $5.61 per share. For Q2, revenue is expected to be in the range of $1.61 billion to $1.65 billion, with non-GAAP EPS between $1.25 and $1.28 per share.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement